Trademark Attorney / Law Firm
Michael and Freeman – Trademark Portfolio
Michael and Freeman specializes in Class 35 (Advertising & Business) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 41 (Education & Entertainment) along with 3 other Nice Classification classes. Filing activity spans from 2021 to 2022. Currently, 1 trademark is registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Michael and Freeman's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademark applications has Michael and Freeman filed?
Michael and Freeman has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 abandoned.
What trademark classes does Michael and Freeman specialize in?
Michael and Freeman has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
How long has Michael and Freeman been filing trademarks?
Michael and Freeman's trademark filing history with the USPTO spans from 2021 to 2022, covering 1 year of trademark practice. During this period, Michael and Freeman has handled 2 trademark applications.
What is Michael and Freeman's trademark registration success rate?
Michael and Freeman has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.